insights_auto
Why is ALK-B down 2.37%?
Dive Deeperchevron_right
ALK-B:CPH
ALK-Abello A/S
DKKÂ 239.20
arrow_downward
-2.37%(-5.80) 1D
Nov 20, 5:00:00 PM GMT+1 · DKK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALK-B...
Open
DKKÂ 243.80
High
DKKÂ 244.00
Low
DKKÂ 238.60
Mkt. cap
48.45B
Avg. vol.
203.93K
Volume
185.88K
52-wk high
DKKÂ 271.40
52-wk low
DKKÂ 191.80
Shares outstanding
202.57M
No. of employees
3K
Open
DKKÂ 243.80
High
DKKÂ 244.00
Low
DKKÂ 238.60
Mkt. cap
48.45B
Avg. vol.
203.93K
Volume
185.88K
52-wk high
DKKÂ 271.40
52-wk low
DKKÂ 191.80
Shares outstanding
202.57M
No. of employees
3K
News stories
From web sources and news partners
FOREX.com
·
2 hours ago
S&P 500, Nasdaq 100 Drive into Correction Territory
TradingKey
·
9 hours ago
S&P 500 Falls Below 200-Day Moving Average: Buy-the-Dip Opportunity or Bear Market Warning?
Beinsure
·
14 hours ago
Vanguard S&P 500 ETF: How investing in VOO could build a $1 mn portfolio
cwibc.co.id
·
4 hours ago
Wall Street Sell-Off Pushes S&P 500 and Dow Into Correction
Profile
ALK-Abelló A/S, also commonly known as ALK, is a Denmark-based pharmaceutical company which specializes in the development and manufacturing of allergy immunotherapy products for the prevention and treatment of allergy. It is one of the world's largest makers of allergy immunotherapy products with 67% of its revenue coming from sales in Europe. Wikipedia
About ALK-Abello A/S
CEOPeter Halling
Employees2.8K
Founded1923
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitealk.net